Internal Medicine, Medical Oncology · Wilmington, NC
NPI
1689600058
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2131 S 17th St
Wilmington, NC, 28401
Phone (910) 667-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
1,779 services
Medicare patients, 2024
676
Average age 75
Drug cost, 2024
$9.7M
2,174 prescriptions
Company payments, 2025
$179
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew M Schreiber was code 99214 (office e&m - established), 1,183 times for 573 patients. In total Andrew M Schreiber billed 1,779 services in 11 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,183 | 573 | $63.97 | $76K |
| 99215 Office E&M - Established | Facility | 400 | 214 | $99.75 | $40K |
| 99205 Office E&M - New | Facility | 116 | 116 | $128.65 | $15K |
| 99223 Hospital E&M - Initial | Facility | 30 | 29 | $128.71 | $3,861 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 14 | $88.35 | $2,120 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $30.94 | $340 |
By year: 2022 $141K for 1,688 services; 2023 $154K for 1,828 services; 2024 $138K for 1,779 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew M Schreiber prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 212 prescriptions and refills. In total Andrew M Schreiber wrote 2,174 Medicare prescriptions that cost $9.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 212 | 212 | 29 | $2.6M |
| Xarelto Rivaroxaban | 163 | 200 | 35 | $110K |
| Prednisone Generic | 146 | 152 | 58 | $645 |
| Ondansetron Hcl Generic | 135 | 135 | 82 | $1,149 |
| Prochlorperazine Maleate Generic | 83 | 83 | 59 | $914 |
| Dexamethasone Generic | 80 | 82 | 39 | $1,114 |
| Imatinib Mesylate Generic | 79 | 80 | Under 11 | $64K |
| Revlimid Lenalidomide | 70 | 70 | Under 11 | $884K |
| Calquence Acalabrutinib Maleate | 59 | 59 | Under 11 | $858K |
| Oxycodone Hcl Generic | 57 | 57 | 15 | $511 |
| Abiraterone Acetate Generic | 52 | 52 | Under 11 | $39K |
| Potassium Chloride Generic | 45 | 45 | 29 | $170 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 43 | 43 | 18 | $472 |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $642K |
| Gabapentin Generic | 40 | 42 | Under 11 | $392 |
Brand drugs: 898 claims; generic drugs: 1,276 claims; opioid claims: 135.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew M Schreiber $179 ($179 in general payments such as food, travel and fees) from 8 companies. The largest payer was Pfizer Inc. with $48.19.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.